Literature DB >> 9414312

Differentiating juvenile myelomonocytic leukemia from infectious disease.

D Pinkel.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9414312

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  21 in total

1.  Choroidal infiltration in juvenile myelomonocytic leukaemia.

Authors:  G C Chang; D M Moshfeghi; D M Alcorn
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

2.  Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.

Authors:  Koichi Moriwaki; Atsushi Manabe; Takeshi Taketani; Akira Kikuchi; Tatsutoshi Nakahata; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2014-09-27       Impact factor: 2.490

3.  Fatal reactivation of postnatal cytomegalovirus infection with rapid emergence of ganciclovir resistance in an infant after allogeneic stem cell transplantation.

Authors:  Sebastian Voigt; Detlef Michel; Olivia Kershaw; Jörn-Sven Kühl; Thomas Mertens; Wolfram Ebell; Helga Meisel
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 4.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

5.  Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.

Authors:  Hirotoshi Sakaguchi; Yusuke Okuno; Hideki Muramatsu; Kenichi Yoshida; Yuichi Shiraishi; Mariko Takahashi; Ayana Kon; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Hideki Makishima; Xinan Wang; Yinyan Xu; Sayoko Doisaki; Asahito Hama; Koji Nakanishi; Yoshiyuki Takahashi; Nao Yoshida; Jaroslaw P Maciejewski; Satoru Miyano; Seishi Ogawa; Seiji Kojima
Journal:  Nat Genet       Date:  2013-07-07       Impact factor: 38.330

6.  Juvenile myelomonocytic leukemia characterized by cutaneous lesion containing Langerhans cell histiocytosis-like cells.

Authors:  Shuichi Ozono; Hiroko Inada; Shin-Ichiro Nakagawa; Koichiro Ueda; Hideki Matsumura; Seiji Kojima; Hiroshi Koga; Takashi Hashimoto; Koichi Oshima; Toyojiro Matsuishi
Journal:  Int J Hematol       Date:  2011-02-25       Impact factor: 2.490

7.  Protein-tyrosine phosphatase Shp2 positively regulates macrophage oxidative burst.

Authors:  Xing Jun Li; Charles B Goodwin; Sarah C Nabinger; Briana M Richine; Zhenyun Yang; Helmut Hanenberg; Hiroshi Ohnishi; Takashi Matozaki; Gen-Sheng Feng; Rebecca J Chan
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

8.  Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Authors:  Elliot Stieglitz; Ashley F Ward; Robert B Gerbing; Todd A Alonzo; Robert J Arceci; Y Lucy Liu; Peter D Emanuel; Brigitte C Widemann; Jennifer W Cheng; Nalini Jayaprakash; Frank M Balis; Robert P Castleberry; Nancy J Bunin; Mignon L Loh; Todd M Cooper
Journal:  Pediatr Blood Cancer       Date:  2014-12-08       Impact factor: 3.167

Review 9.  Pediatric Neoplasms Presenting with Monocytosis.

Authors:  Jacob R Greenmyer; Mira Kohorst
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

10.  Granulocytic sarcoma presenting with severe adenopathy (cervical lymph nodes, tonsils, and adenoids) in a child with juvenile myelomonocytic leukemia and successful treatment with allogeneic bone marrow transplantation.

Authors:  Toshihiko Imamura; Satoshi Matsuo; Takao Yoshihara; Tomohiro Chiyonobu; Kanako Mori; Hiroyuki Ishida; Yasutaka Nishimura; Yasuo Kasubuchi; Mayumi Naya; Akira Morimoto; Shigeyoshi Hibi; Shinsaku Imashuku
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.